report
acut
encephalopathi
associ
infl
uenza
infect
adult
detect
high
cerebrospin
fl
uid
csf
plasma
concentr
csfplasma
ratio
evid
viral
neuroinvas
patient
recov
without
sequela
hyperactiv
cytokin
respons
may
play
role
pathogenesi
nasopharnyg
aspirateifa
patient
receiv
antivir
treatment
patient
recov
next
day
patient
fever
sever
chronic
obstruct
pulmonari
diseas
exacerb
requir
noninvas
ventilatori
support
complic
acut
coronari
syndrom
given
oseltamivir
mg
infl
uenza
infect
confi
rmed
agit
confus
develop
patient
day
ill
onset
third
dose
oseltamivir
despit
resolut
patient
respiratori
failur
symptom
follow
involuntari
tremul
movement
involv
limb
rest
movement
brain
ct
scan
normal
electroencephalogram
show
gener
slow
oseltamivir
stop
ninth
dose
tremor
persist
csf
analys
show
pathogen
pleocytosi
patient
symptom
resolv
next
day
without
sequela
despit
appar
normal
csf
fi
nding
high
concentr
cytokineschemokin
detect
csf
plasma
specimen
patient
tabl
plasma
concentr
elev
median
valu
upper
limit
respect
refer
rang
compar
higher
observ
hospit
infl
uenza
patient
tabl
cytokin
elev
csf
consist
detect
elev
median
valu
upper
limit
respect
plasma
refer
rang
csfplasma
concentr
ratio
median
csfplasma
ratio
respect
simultan
csf
plasma
oc
op
concentr
determin
patient
symptom
progress
h
oseltamivir
concentr
mean
sd
oc
duplic
csf
plasma
sampl
ngml
ngml
respect
csfplasma
concentr
ratio
op
plasma
concentr
ngml
detect
csf
report
adult
acut
encephalopathi
alter
conscious
confus
associ
infl
uenza
high
csf
blood
cytokinechemokin
level
detect
ev
idenc
direct
viral
neuroinvas
found
patient
recov
rapidli
without
sequela
fi
nding
agre
studi
infl
uenzaassoci
encephalopathi
children
infl
uenza
viru
rare
detect
csf
pleocytosi
often
absent
high
level
cytokin
eg
solubl
tumor
necrosi
factor
receptor
consist
found
csfblood
specimen
correl
diseas
sever
outcom
hyperactiv
cytokin
respons
absent
febril
seizur
associ
infl
uenza
found
broader
rang
cytokineschemokin
activ
certain
cytokin
csf
concentr
plasma
shown
play
pathogen
role
cn
viral
infect
cerebr
injuri
acut
brain
syndrom
suscept
patient
high
csfplasma
ratio
suggest
cytokin
activ
within
cn
might
occur
along
respiratorytract
system
product
cytokin
detect
csf
normal
tabl
resid
macrophagesmonocyt
astrocyt
microgli
endotheli
cell
cn
shown
releas
cytokineschemokin
stimul
viral
infl
uenza
infect
activ
mechan
without
involv
overt
cn
invas
suggest
cytokin
may
caus
direct
neurotox
effect
cerebr
metabol
chang
breakdown
bloodbrainbarri
endotheli
injuri
produc
symptom
whether
earli
viral
suppress
antivir
lead
attenu
cytokin
respons
better
outcom
warrant
studi
measur
oseltamivir
concentr
concern
neuropsychiatr
sideeffect
children
adolesc
howev
activ
metabolit
oc
detect
csf
patient
csfplasma
concentr
ratio
ngml
postdos
degre
csf
penetr
similar
observ
among
healthi
patient
cmax
csfplasma
concentr
ratio
hour
ratio
hour
concentrationtim
profi
le
plasmacsf
differ
assum
similar
ratio
csf
op
concentr
would
fallen
assay
detect
limit
ngml
hour
low
csf
drugpenetr
togeth
high
cytokin
csf
symptom
progress
despit
drug
withdraw
suggest
manifest
patient
may
diseaserel
symptom
develop
patient
without
antivir
exposur
investig
cn
effect
oseltamivir
clinic
set
need
studi
limit
small
patient
number
lack
feasibl
obtain
csf
studycomparison
infl
uenza
patient
without
neurolog
symptom
studi
clinic
spectrum
infl
uenza
encephalopathi
enceph
adult
pathogenesi
indic
conclus
acut
encephalopathi
may
occur
adult
infl
uenza
exuber
pediatr
influenza
cohort
csf
cytokin
level
substanti
higher
encephalopathi
case
compar
febril
seizur
csfplasma
concentr
cytokin
concentr
plasma
refer
rang
cytokin
concentr
ratio
consist
addit
csf
cytokin
concentr
plasma
refer
rang
ifn
tnf
rant
lowundetect
level
csfplasma
ratio
calcul
csf
specimen
patient
collect
peak
symptom
antivir
treatment
given
csf
patient
collect
persist
tremor
develop
hour
ninth
dose
oseltamivir
drug
stop
afterward
cytokinechemokin
respons
may
play
import
role
pathogenesi
